Summary
Private equity firm Creador is in advanced talks to acquire a stake in generic drug company Leeford Healthcare, with an expected investment of ₹800 crore. This deal would value Leeford Healthcare at ₹8,000-₹8,500 crore and marks the company's first ownership dilution to an external investor.